Table S2 from Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody–Drug Conjugate for the Treatment of Solid Cancers
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Equilibrium dissociation constant of binding of MGC028 and MGA027 to human and cynomolgus monkey ADAM9
Fields of Study & Subjects
Monoclonal and Polyclonal Antibodies Research
Toxin Mechanisms and Immunotoxins
Protein Degradation and Inhibitors
Publication details
- Publication date
- 2 April 2026
- Language
- EN